Your search terms:
John a jenkins
Search results sorted by date
Analytics
Early Signals from FOIA Requests Show How Trump Actions Will Be Targeted
FOIAengine: Journalists and Non-Profits Gear Up
Within hours of President Donald Trump’s inauguration on January 20, news media organizations and non-profits began filing Freedom of...
Analytics
Questioning U.S. Readiness for Deepfake Attacks
FOIAengine: Homeland Security Report, Media Requests Highlight the Issue
When a deepfake photo of an explosion near the Pentagon caused investor panic in 2023, the...
Analytics
Mastermind of the Federal Spending Freeze
FOIAengine: Vought’s Center for Renewing America Shows the Priorities of OMB’s New Director. But Will He Be in Synch with Musk?
This week, we’re looking...
Analytics
How Project 2025 Targets Pentagon Leadership
FOIAengine: Over 1,500 Requests Probe Views Using FOIA
A new FOIAengine analysis of just-released Department of Defense Freedom of Information Act requests reveals the extent...
Analytics
The Growing Litigation Threat to Starbucks
FOIAengine Breaks Down Court Cases, NLRB Actions, and Recent FOIA Requests
On Brian Niccol’s first day four months ago as the new CEO of Starbucks,...
Analytics
More Questions About Obesity Drug Makers
FOIAengine: How Lilly, Novo Nordisk, Others Use FOIA
Welcome to 2025. At PoliScio Analytics, we logged 45,720 federal FOIA requests into our FOIAengine database during...
Analytics
Questioning a Monopoly in Outer Space
FOIAengine: Reporter Seeks Answers About NASA-SpaceX Relationship
SpaceX has had a good year. In June, the National Aeronautics and Space Administration (NASA) awarded SpaceX a...
Analytics
Media Seeks Kennedy’s Recent FDA Contacts
FOIAengine: HHS Designee Is Target After Calling FDA “Corrupt”
Freedom of Information Act requests from the news media about Robert F. Kennedy Jr. hit the...
- Advertisement -
Latest news
Latham and Covington Advise on Novartis’s Acquisition of Regulus
Novartis announced plans to acquire Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company developing medicines targeting microRNAs, for $800...
The Crook, the Tycoon, the Short Seller, and Trump
FOIAengine Tracks the High Cost of Getting Even, and the Rewards
Until six weeks ago, Jason Galanis was Inmate 80739-198...
Pharma Knock-Offs, a Secret Email Address, and a Smooth Spin of the Revolving Door
The Latest Requests Logged in FOIAengine
Questions about GLP-1 weight loss drugs, DOGE, cryptocurrencies, and the past conduct of Trump’s...
